Mr Hodgkin’s disease

Volker Diehl cultured the cells that characterise Hodgkin’s disease when everyone else had failed. He has high hopes that molecular medicine will throw light on many questions that remain unanswered. But he stresses that it [more]

A trial of strength

Patients, doctors, academic researchers and the World Health Organization all want industry to be a lot more open about the drugs they are trialling. The industry is pleading commercial confidentiality. The two sides are locked [more]

UA-77507851-1